Laycock Willoughby B. 4

Accession 0000907254-25-000026

CIK 0000907254other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 5:48 PM ET

Size

23.8 KB

Accession

0000907254-25-000026

Form 4

Period: 2025-03-06

DirectorSVP-Res. Design/Mrkt Research

Transactions

Exercise/Conversion
Performance Shares
2025-03-06−100→ 400 total
Exercise: $0.00From: 2029-05-17Exp: 2029-05-17→ Common Stock (100 underlying)
Exercise/Conversion
Common Stock
2025-03-06+100→ 3,551.068 total
Award
Common Stock
2025-03-06+50→ 3,601.068 total

Holdings

Employee Stock Option
Exercise: $43.89From: 2021-05-07Exp: 2031-05-07→ Common Stock (10,000 underlying)
10,000
Employee Stock Option
Exercise: $47.90From: 2022-05-13Exp: 2032-05-13→ Common Stock (10,000 underlying)
10,000
Employee Stock Option
Exercise: $33.79From: 2023-05-12Exp: 2033-05-12→ Common Stock (10,000 underlying)
10,000
Director Stock Option
Exercise: $43.89From: 2021-05-07Exp: 2031-05-07→ Common Stock (2,500 underlying)
2,500
Director Stock Option
Exercise: $47.90From: 2022-05-13Exp: 2032-05-13→ Common Shares (2,500 underlying)
2,500
Common Stock
(indirect: By Spouse)
249.952
Employee Stock Option
Exercise: $55.71From: 2019-05-03Exp: 2029-05-03→ Common Stock (5,000 underlying)
5,000
Employee Stock Option
Exercise: $50.00From: 2020-04-24Exp: 2030-04-24→ Common Stock (10,000 underlying)
10,000
Phantom Stock
→ Common Stock (3,861.986 underlying)
3,861.986
Director Stock Option
Exercise: $55.71From: 2019-05-03Exp: 2029-05-03→ Common Stock (2,500 underlying)
2,500
Director Stock Option
Exercise: $50.00From: 2020-04-24Exp: 2030-04-24→ Common Stock (2,500 underlying)
2,500
Director Stock Option
Exercise: $33.79From: 2023-05-12Exp: 2033-05-12→ Common Stock (2,500 underlying)
2,500

Footnotes (6)

[F1]Represents restricted shares of Common Stock. Such shares vest, assuming continued employment, on May 17, 2029.
[F2]Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2024 and ending on December 31, 2024. Such shares vest, assuming continued employment, on May 17, 2029.
[F3]The options vest 25% per year over four years from the date of grant.
[F4]Phantom shares are issuable pursuant to the Issuer's Deferred Compensation Plan for Directors under its 2004 Stock Plan, as amended (the "Deferred Compensation Plan"). Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service.
[F5]The conversion of the phantom stock into shares of the Issuer's common stock is governed by the Deferred Compensation Plan and the reporting person's Deferred Fee Election Agreement.
[F6]Includes 63.183 shares awarded January 31, 2025 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.

Documents

1 file

SAUL CENTERS, INC.

CIK 0000907254

Entity typeother